The migration distance was notably decreased in cells treated with siFOXP3#1 and siFOXP3#2 compared to the control, indicating that FOXP3 supports the invasive properties of ccRCC cells. This evidence concerns the gene FOXP3 and nonpapillary renal cell carcinoma.